ArticlebioRxiv : the preprint server for biology2025
SurfDiff: protein surface profiling for selective or broadly reactive epitope prioritisation in binder and immunogen design.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Rational selection of protein-surface patches - epitopes or ligandable sites - is essential for developing targeted antibodies, binding proteins, peptides, or small-molecule ligands, and for informing immunogen design in vaccines. We present SurfDiff, a structure- and sequence-informed framework for protein surface comparison. SurfDiff supports one-to-one and one-to-many comparisons by combining local structural alignments with physicochemically and spatially aware neighbourhood analysis. It assigns residue-level uniqueness and similarity scores, which can be aggregated into surface-level similarity, selectivity, and a discriminability score that captures conservation across desired targets while penalising similarity to undesired off-targets. These scores, calculated solely from the targets without any knowledge of the binders, reliably predict known experimental selectivity for diverse binders including small molecules, peptides, antibodies and antibody mimetics across viral antigens, cytokine isoforms, GPCR subtypes and serum albumin. They also correlate strongly with binding and neutralisation data across pathogen variants, and substantially outperform commonly used bioinformatic metrics such as sequence substitution matrices and structural similarity measures. SurfDiff provides a generalisable and interpretable approach to protein surface profiling, enabling selective or cross-reactive binder design, cross-species prioritisation, and facilitating immunogen selection. We make SurfDiff available as downloadable open-source software: (https://gitlab.developers.cam.ac.uk/ch/sormanni/surfdiff) and as a webserver: www-cohsoftware.ch.cam.ac.uk/index.php/surfdiff.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.